The structure of a protein and/or its expression might change by polymorphism of the specific gene, thus, innate and adaptive immunity may be compromised 13, 27 . Therefore, gene polymorphisms might have a deterministic importance in disease outcome.
One of the most important factors responsible for periodontal destruction is the upregulation of proinflammatory cytokines. Interleukin-6 (IL-6), as one of these pro-inflammatory cytokines, was reported to be an effective stimulator of osteoclast differentiation and bone resorption
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. Along with CP, several inflammatory diseases were also associated with elevated levels of IL-6 12, 17 . On the other hand, anti-inflammatory cytokines such as IL-10 can restore balance by inhibiting synthesis of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and stimulating protective antibody production 20, 26 . For this reason, IL-10 gene polymorphism might contribute to periodontitis development.
The gene encoding human IL-10 is located on chromosome one (1q31-32). IL-10 three biallelic polymorphisms within the IL-10 promoter region, at surgical periodontal therapy was performed under local anesthesia in four sessions, one quadrant in each session with site-specific gracey curettes (Hu-Friedy, Chicago, IL, USA). PI, GI, PD, CAL measurements were recorded and blood samples were taken at both the baseline and the sixth week of study.
GCF sampling
Single-rooted teeth with moderate PD and CAL were chosen for GCF sampling in CP patients and equivalent teeth with healthy periodontium in HC group. GCF sampling was performed in proximal sites of the chosen tooth with a paper strip (ProFlow Inc., Amityville, NY, USA). The strip was placed into periodontal pocket in CP patients and gingival sulcus in HC group until a mild resistance was felt and held in place for 30 seconds 14 . Mechanical trauma and contamination of strip with saliva and/or blood were avoided. Contaminated strips were excluded and sampling was repeated 30 minutes later. All strips were placed into eppendorf tubes individually and kept at -80°C until ELISA analysis.
Serum collection
To obtain serum samples, 5 mL of venous blood from antecubital vein were driven from each participant and placed into biochemical tubes containing an anticoagulant agent. Blood samples in tubes were allowed to rest for 30 minutes and then centrifuged at 6,000 rpm for 10 minutes. Serum was separated from tube and placed into eppendorf tubes. All serum samples were kept at -80°C until analysis.
ELISA analysis
We added 100 µL of phosphate buffer solution into eppendorf tubes containing paper strips and mixed via vortex for a minute. IL-6 and IL-10 levels in GCF and serum samples were determined via ELISA kits (Invitrogen, Cambrillo, USA) according to the manufacturer's protocol. After the procedure, plates were read on a spectrometer at 450 nm wavelength.
The results were converted to numeric values by using standard curves.
DNA extraction and genotyping
The study protocol was carried out about our previous study 7 . For DNA extraction and genotyping, 2 mL of blood from the antecubital vein was driven from all participants and placed into biochemical tubes containing sodium EDTA. Tubes were then kept at -80°C until the genetic analysis day. A commercial kit (Invitrogen, Cambrillo, USA) was used for DNA extraction according to the manufacturer's instructions.
IL-10 gene polymorphism was evaluated via PCR-RFLP
by analyzing IL-10 gene at position -597. Table 1 
Statistical evaluation
We performed statistical analysis using SPSS 
Biochemical parameters
At the 6 th week, IL-6 and IL-10 levels in GCF were lower than baseline in CP group (p<0.05) ( Table 3) .
Both baseline and 6 th week levels of IL-6 in GCF of CP group were higher than those of the HC group (p<0.05). However, unlike GCF levels, serum levels of IL-6 and IL-10 in the CP group did not change after periodontal treatment (p>0.05). In the comparison between groups, serum cytokine levels were higher in the CP group than those of the control group (p<0.05).
According to the ratio of IL-6/IL-10, serum and GCF IL-6/IL10 levels were significantly higher in the CP group than those of the control group (p<0.05).
However, baseline and 6 th week values of IL-6/IL-10 ratio in GCF and serum were similar (p>0.05). We evaluated the changes in clinical and biochemical parameters in the CP group after categorizing patients according to IL-10 genotype distribution (IL-10 AA and AC+CC). Periodontal treatment provided significant improvements in both genotypes (p<0.05) (Table 4) .
CP n=51 C n=50 P-value
However, clinical parameters between IL-10 AA and AC+CC genotypes were similar in both baseline and 6 th week (p>0.05) ( Table 5 ).
GCF IL-10 levels at the 6 th week in patients carrying IL-10 AC+CC genotype significantly decreased (p<0.05) ( Table 4 Periodontal disease susceptibility in the CP group was evaluated with logistic regression analysis of IL-10 AA genotypes after adjustment of age and sex.
Genotype diversity was not affected by either age or sex.
Discussion
The complexity of cytokine network, together with gene polymorphisms of these cytokines, aids in uncovering the molecular mechanisms of inflammatory diseases, such as periodontal diseases. In this way, our study evaluated the role of anti-inflammatory (IL-10) and proinflammatory cytokines (IL-6) in chronic periodontitis patients. Correlation of these results with the gene polymorphism of IL-10 was also performed.
As a result, we found that IL-10 AA genotypes were associated with chronic periodontitis and IL-10 AA genotype carriers showed lower IL-6/IL-10 levels in serum.
In this study, patients with the IL-10 AA genotype had a high susceptibility to chronic periodontitis.
Similarly to our results, Sumer, et al. . Although A alleles were higher in CP groups in this study, our results showed that the allele frequencies did not differ between chronic periodontitis and healthy control groups.
However, Jaradat, et al. 14 (2012) Table 4 -Gingival crevicular fluid (GCF) and serum IL-6, IL-10 levels and IL-6/IL-10 ratio at baseline and 6-week according to In this study, we did not assess the haplotype analyses for this gene locus, which may be considered a shortcoming. Also, another limitation of this study is the low number of subjects included. However, we excluded periodontitis smoker patients because of the effects of smoking on the immune system.
Conclusion
In conclusion, this study demonstrated that IL-10 -597 AA genotype appeared to be a risk factor for chronic periodontitis. Furthermore, genetic polymorphisms in the IL-10 gene might be useful as a marker to diagnose susceptibility to CP. On the other hand, an important finding of this study is that IL-10 AA genotype may tend to reduce IL-6 production or contribute to the inflammatory status, along with decreased GCF IL-10 levels. Nonetheless, further studies are needed to elucidate the mechanisms involved in cytokine gene polymorphisms and their production in periodontal disease.
